Procymate
From Wikipedia, the free encyclopedia
Jump to: navigation, search
| Clinical data | |
|---|---|
| Routes of administration |
oral |
| ATC code |
|
| Identifiers | |
|
|
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C10H19O2 |
| Molar mass | 185.263 g/mol |
| 3D model (JSmol) | |
|
|
|
|
| |
|
Procymate (Equipax) is a carbamate derivative which is a sedative and anxiolytic drug. It was previously manufactured and marketed in Belgium. The usual dose for adults is 800 to 1200 mg per day.[1] Procymate shares a similar structure and mechanism of action with the related drugs hexapropymate and phenprobamate.
References[edit]
- ^ "Procymate," Bank of Automated Data on Drugs. VIDAL Drug Database. <http://www.biam2.org/www/Sub394.html>
| Alcohols | |
|---|---|
| Barbiturates |
|
| Benzodiazepines |
|
| Carbamates | |
| Flavonoids |
|
| Imidazoles | |
| Kava constituents | |
| Monoureides | |
| Neuroactive steroids |
|
| Nonbenzodiazepines |
|
| Phenols | |
| Piperidinediones | |
| Pyrazolopyridines | |
| Quinazolinones | |
| Volatiles/gases |
|
| Others/unsorted |
|
| This sedative-related article is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=Procymate&oldid=713235690"